Imaging utilization increaseswhere radiologists wane
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions.
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions. According to Thomas Jefferson University researchers, the areas with the highest utilization rates also have the lowest percentage of radiologists.
TJU radiology chair Dr. Vijay Rao and colleagues looked at trends in noninvasive imaging services over a five-year period ending in 2006 using the Medicare Part B feefor- service database. In 2006, utilization rates per 1000 beneficiaries ranged from a high of 4532 in the Atlanta region to a low of 2901 in the Seattle region. Radiologists’ share of the imaging services provided ranged from 69% in the Boston region to a low of 58% in the Atlanta region. Plotting radiologist share against the overall utilization rates showed that the higher the utilization rate, the lower the percentage of radiologists providing the services. Rao released findings at the 2008 RSNA meeting.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
